Avidity Partners Management »

Nuvectis Pharma shares owned by Avidity Partners Management

Quarter-by-quarter ownership of Nuvectis Pharma (NVCT) shares owned by Avidity Partners Management from 13F filings

Historical chart of Avidity Partners Management investment in Nuvectis Pharma

Tip: Access up to 7 years of quarterly data

All positions including Nuvectis Pharma held by Avidity Partners Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvectis Pharma by Avidity Partners Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.7M 200k 18.39

More positions owned by Avidity Partners Management

Dianthus Therapeutics (DNTH)
Cg Oncology (CGON)
Oruka Therapeutics (ORKA)
Jade Biosciences Com New (JBIO)
Enliven Therapeutics (ELVN)
Perspective Therapeutics Com New (CATX)
Aktis Oncology (AKTS)
Palvella Therapeutics Inc Ne (PVLA)
Mobia Med Common Stock
Repligen Corporation (RGEN)
Immunic Com New (IMUX)
Senseonics Hldgs (SENS)
Karyopharm Therapeutics Com New (KPTI)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Dex (DXCM)

View all positions for Avidity Partners Management

Top funds holding Nuvectis Pharma

Tang Capital Management
BlackRock
Soleus Capital Management
Perceptive Advisors
Vanguard Capital Management
Iridian Asset Management
Geode Capital Management
Sphera Funds Management
Baldwin Brothers
Occam Crest Management
Susquehanna International
Alyeska Investment Group
Avidity Partners Management
Citadel Advisors
State Street Corporation

View all funds holding Nuvectis Pharma